MyFinsight
Home
Blog
About
Income Statement
|
Cash Flow
|
Balance Sheet
|
Ratios
Income Overview
Revenue
$1,157K
Net Income
-$79,056K
Net Profit Margin
-6832.84%
EPS
-$0.9
Unit: Thousand (K) dollars
Revenue Breakdown
Commercial And Development Reven...
License And Collaboration Revenu...
Subscribe for Financial Insights
Page 1
Quarterly
123
Page 1
Income Statement
2026-06-30
2026-03-31
2025-12-31
2025-09-30
Total revenues
1,157
1,083
1,463*
1,666
Cost of sales
3,925
2,962
-84*
1,577
Research and development
54,657
43,730
35,980*
27,884
General and administrative
28,976
20,780
16,342*
23,334
Total operating costs and expenses
87,558
67,472
52,237*
52,795
Loss from operations
-86,401
-66,389
-50,774*
-51,129
Interest income, net
7,329
6,288
7,180*
7,421
Other income (expense), net
16
-101
-9*
-100
Total other income, net
7,345
6,187
7,170*
7,321
Net loss and comprehensive loss
-79,056
-60,202
-43,605
-43,808
Net loss attributable to common stockholders
-
-
-43,605
-
Basic EPS
-0.9
-0.71
-0.552
-0.57
Diluted EPS
-0.9
-0.71
-0.552
-0.57
Basic Average Shares
88,200,023
84,518,512
78,992,973
76,729,726
Diluted Average Shares
88,200,023
84,518,512
78,992,973
76,729,726
Page 1
Unit: Thousand (K) dollars (except for numbers of shares and EPS). Numbers labeled with * are estimated quarterly values.
Page 1
Buy us a coffee
Time Plot
Show the time plot by selecting a row from the table.
Income Statement
Interest income, net
$7,329K
Other income
(expense), net
$16K
Net loss and
comprehensive loss
-$79,056K
Total other income,
net
$7,345K
Commercial And Development
Revenue
$1,147K
License And
Collaboration Revenue
$10K
Loss from operations
-$86,401K
Total revenues
$1,157K
Total operating costs
and expenses
$87,558K
Research and development
$54,657K
General and
administrative
$28,976K
Cost of sales
$3,925K
Buy us a coffee
CG Oncology, Inc. (CGON)
CG Oncology, Inc. (CGON)